These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30797713)
61. Proteome-wide Tyrosine Phosphorylation Analysis Reveals Dysregulated Signaling Pathways in Ovarian Tumors. Song G; Chen L; Zhang B; Song Q; Yu Y; Moore C; Wang TL; Shih IM; Zhang H; Chan DW; Zhang Z; Zhu H Mol Cell Proteomics; 2019 Mar; 18(3):448-460. PubMed ID: 30523211 [TBL] [Abstract][Full Text] [Related]
62. GATA6: a new predictor for prognosis in ovarian cancer. Shen W; Niu N; Lawson B; Qi L; Zhang J; Li T; Zhang H; Liu J Hum Pathol; 2019 Apr; 86():163-169. PubMed ID: 30633927 [TBL] [Abstract][Full Text] [Related]
63. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma]. Xiang L; Li J; Wang LJ; Zheng WX; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344 [TBL] [Abstract][Full Text] [Related]
64. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature. Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633 [TBL] [Abstract][Full Text] [Related]
65. PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors. Lohneis P; Darb-Esfahani S; Dietel M; Braicu I; Sehouli J; Arsenic R Anticancer Res; 2015 Nov; 35(11):6329-34. PubMed ID: 26504072 [TBL] [Abstract][Full Text] [Related]
66. [Expression of IL10 in epithelial ovarian tumor tissue and cell line and its clinical significance]. Zhou JW; Qian YS; Xie X; Lu WG; Chen HZ Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1911-3. PubMed ID: 15631806 [No Abstract] [Full Text] [Related]
67. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Wen YH; Yee H; Goswami S; Shukla PS Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814 [TBL] [Abstract][Full Text] [Related]
68. WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer. Lee S; Jun J; Kim WJ; Tamayo P; Howell SB Anticancer Res; 2020 Nov; 40(11):6017-6028. PubMed ID: 33109540 [TBL] [Abstract][Full Text] [Related]
69. FGF18 as a potential biomarker in serous and mucinous ovarian tumors. El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667 [TBL] [Abstract][Full Text] [Related]
70. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas]. Shen XX; Yu L; Bi R; Yang WT Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637 [TBL] [Abstract][Full Text] [Related]
71. Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma. Shih IeM; Nakayama K; Wu G; Nakayama N; Zhang J; Wang TL Mod Pathol; 2011 May; 24(5):638-45. PubMed ID: 21240255 [TBL] [Abstract][Full Text] [Related]
72. Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary. Ota T; Clayton AC; Minot DM; Shridhar V; Hartmann LC; Gilks CB; Chien JR Mod Pathol; 2011 Feb; 24(2):277-87. PubMed ID: 21076460 [TBL] [Abstract][Full Text] [Related]
73. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway. Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466 [TBL] [Abstract][Full Text] [Related]
74. [Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features]. Guo DH; Zheng WX Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):624-8. PubMed ID: 24314254 [No Abstract] [Full Text] [Related]
75. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors. Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389 [TBL] [Abstract][Full Text] [Related]
76. Expression of Fas and FasL in human serous ovarian epithelial tumors. van Haaften-Day C; Russell P; Davies S; King NJ; Tattersall MH Hum Pathol; 2003 Jan; 34(1):74-9. PubMed ID: 12605369 [TBL] [Abstract][Full Text] [Related]
77. High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer. Li M; Cheng X; Rong R; Gao Y; Tang X; Chen Y BMC Cancer; 2020 Oct; 20(1):1032. PubMed ID: 33109151 [TBL] [Abstract][Full Text] [Related]
78. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors]. Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848 [TBL] [Abstract][Full Text] [Related]
79. Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer. Medrano M; Communal L; Brown KR; Iwanicki M; Normand J; Paterson J; Sircoulomb F; Krzyzanowski P; Novak M; Doodnauth SA; Saiz FS; Cullis J; Al-Awar R; Neel BG; McPherson J; Drapkin R; Ailles L; Mes-Massons AM; Rottapel R Cell Rep; 2017 Mar; 18(10):2343-2358. PubMed ID: 28273451 [TBL] [Abstract][Full Text] [Related]
80. Frontiers in the Pathology and Pathogenesis of Ovarian Cancer: Cancer Precursors and "Precursor Escape". Soong TR; Dinulescu DM; Xian W; Crum CP Hematol Oncol Clin North Am; 2018 Dec; 32(6):915-928. PubMed ID: 30390765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]